Neuronal voltage-gated sodium channel (NaV1.x) (NaV1.x)

Neuronal voltage-gated sodium channels (NaV1.x) are critical transmembrane proteins responsible for the rapid influx of sodium ions that initiates and propagates action potentials in neurons (StatPearls, 2023). This family includes several isoforms (NaV1.1, 1.2, 1.3, 1.6, 1.7, 1.8, and 1.9) distributed throughout the central and peripheral nervous systems (UniProt, 2024). Each channel is composed of a large, pore-forming alpha subunit and auxiliary beta subunits that regulate channel trafficking and kinetics (PubMed, PMID: 29466316). Mutations in the genes encoding these channels are primary drivers of various channelopathies, including severe forms of epilepsy like Dravet syndrome and chronic pain conditions like small fiber neuropathy (NIH, 2023). Therapeutically, NaV1.x channels are targeted by a wide range of anticonvulsants and local anesthetics that stabilize the channel in its non-conducting inactivated state (PubChem, 2024). Modern drug discovery efforts focus on developing isoform-selective inhibitors to minimize off-target effects, particularly avoiding the cardiac NaV1.5 isoform to ensure cardiovascular safety (Journal of Medicinal Chemistry, 2022).

Other names

Voltage-gated sodium channelVGSCSodium channel protein type alpha subunitNaV channelNeuronal sodium channel

Drugs typically act as pore blockers or gating modifiers that bind to the alpha subunit, often showing preference for the inactivated state of the channel to inhibit high-frequency firing without affecting normal signaling (StatPearls, 2023; PubMed, PMID: 30234150).